Emergent Biosystems (NYSE:EBS) inks an agreement with GlaxoSmithKline (NYSE:GSK) to acquire raxibacumab, a fully human monoclonal antibody for the treatment and prevention of inhaled anthrax, for $76M in upfront cash and up to $20M in milestones.
OpGen, Inc. (NASDAQ:OPGN) announces the closing of its previously announced public offering of 18,164,195 units at $0.40 per unit, and 6,835,805 pre-funded units at $0.39 per pre-funded unit, raising gross proceeds of approximately $10 million. The Company intends to use the net proceeds of this offering for general corporate purposes, including working capital and product development, particularly development of its rapid antibiotic resistance diagnostic product, and repayment of all outstanding bridge financing notes.
OMNITEC Solutions, Inc.’s Health Services Division will continue and expand their support of the National Institutes of Health (NIH), National Institute of Mental Health (NIMH) Data Archive (NDA) with a $38 Million firm-fixed-price contract award.
Since 2008, OMNITEC has supported the NIMH making the NDA the model for data sharing and computational science infrastructure at the NIH. Initially created to support 11 autism grants, the NDA now supports and shares data in mental health and substance use from over 800 projects, representing a public and private investment of $1.5 Billion.
We all have some preconceived ideas about the nature of entrepreneurialism. But, according to business master himself, Tony Robbins, starting a company or two does not an entrepreneur make. Financial savvy and business acumen may be enough to get a startup off the ground. But it takes a true entrepreneur to see beyond the creation of a project, propel past the daily managerial duties and take the all-important risks to achieve greatness.
SBIR Program Contract Solicitation
PHS 2018-1
Deadline October 20, 2017, 5:00PM ET
The National Heart, Lung, and Blood Institute invites small business concerns to submit research proposals under the Small Business Innovation Research (SBIR) Contract Solicitation. Firms with the capability to conduct research and development (R&D) in any of the health-related topic areas below and to commercialize the results of that R&D, are encouraged to participate.
- Devices for Transcatheter Surgery
- Tapered Guidewires for Transcatheter Electrosurgery
- Reagent Development for Small Cell Number ChIC-seq
The BIO International Convention is the industry conference for those in or doing business with the biotech industry. MCEDC’s Lynne Stein Benzion, Director of Business Retention and Expansion, is a veteran of several BIO conferences and offered her reflections on this year’s event, which took place June 19-22 in San Diego and drew more than 16,000 industry leaders from 48 states, the District of Columbia, Puerto Rico and 73 countries.
Noble Life Sciences, a contract research organization (CRO) providing services to support the development of drugs, vaccines, and medical devices, is pleased to announce that it has been granted a renewal of full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council on Accreditation. Noble was first awarded AAALAC full accreditation in October 10, 1989.
Accenture Interactive, Marriott International, and 1776, a leading global incubator and network for startups, today announced the launch of the Travel Experience Incubator, a new program designed to discover and foster startups working on innovative technologies and solutions to improve the travel experience. The incubator will bring together the hospitality industry expertise of one of the world’s most innovative companies, Marriott International, and its official Travel Experience Incubator partner, Accenture Interactive, along with participating startups, to co-create unique and inventive new experiences for travelers.
SNNLive spoke with Richard Bendis, President and CEO of BioHealth Innovation, Inc., a private company, at the BioMaryland Pavilion at the BIO International Convention 2017 in San Diego, CA.
In monetary terms, D.C.’s tech scene has been doing pretty well with investors lately: Local start-ups took in about $435 million between April and June 2017, compared with $298 million over the same period four years ago, according to Pitchbook investment data analyzed by the National Venture Capital Association.